Sullivan SG, Khvorov A, Carolan L, Dowson L, Hadip. Antibody responses against influenza A decline with successive years of annual influenza vaccination. NPJ Vaccines. 2025 Jan 17;10(1):11
Influenza vaccine effectiveness and immunogenicity can be compromised with repeated vaccination. We assessed immunological markers in a cohort of healthcare workers (HCW) from six public hospitals around Australia during 2020-2021. Sera were collected pre-vaccination and ~14 and ~180 days post-vaccination and assessed in haemagglutination inhibition assay against egg-grown vaccine and equivalent cell-grown viruses. Responses to vaccination were compared by the number of prior vaccinations. Baseline sera were available for 595 HCW in 2020 and 1031 in 2021. 5% had not been vaccinated during five years prior to enrolment and 55% had been vaccinated every year. Post-vaccination titres for all vaccine antigens were lowest among HCW vaccinated in all 5-prior years and highest among HCW with 0 or 1 prior vaccinations, even after adjustment. This was observed for both influenza A subtypes and was dependent on pre-vaccination titre. Expanded cohorts are needed to better understand how this translates to vaccine effectiveness.
See Also:
Latest articles in those days:
- Based on the MaxEnt model the analysis of influencing factors and simulation of potential risk areas of human infection with avian influenza A (H7N9) in China 19 hours ago
- WPRO/WHO: Avian Influenza Weekly Update, 17 January 2025 2 days ago
- Retrospective modelling of the disease and mortality burden of the 1918-1920 influenza pandemic in Zurich, Switzerland 3 days ago
- Avian Influenza incidents and depopulation methods Feb 2022 to June 2024 in U.S. 3 days ago
- [preprint]From Birds to Bovine: A Review and Critical Analysis of the Outbreaks of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b in the United States 3 days ago
[Go Top] [Close Window]